Today, Lonza is a global leader in life sciences operating across five continents. While we work in science, there’s no magic formula to how we do it. Our greatest scientific solution is talented people working together,
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS-addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
IT Strategic Initiatives Lead Location: Basel, Switzerland Hybrid Working Policy Reporting to the Group Head of Strategy, Governance & Transformation, the Strategic Initiatives Lead is a highly visible position operating at the heart of the global IT
Revolution Medicines is a late-stage clinical oncology company developing novel targeted therapies for patients with RAS‑addicted cancers. The company’s R&D pipeline comprises RAS(ON) inhibitors designed to suppress diverse oncogenic variants of RAS proteins. The company’s RAS(ON)
Company DescriptionSobi offers the opportunity to work at an international pharmaceutical company focused on specialty pharmaceuticals meeting the high medical needs of rare disease patients and providing treatment and services to them. Our employees come from
Role OverviewThe Senior IT Finance Business Partner provides strategic financial leadership to an assigned technology function. Embedded within IT and reporting to the Head of IT Business Management, the role connects technology leadership with IT Business Management,
